Researchers and Clinicians to Collaborate on Cancer Care at Symposium
ALBANY, N.Y., Oct. 1, 2013 — Nationally recognized cancer experts will discuss transforming basic science into clinical practice at the 7th Annual Translational Oncology Research Symposium to be held October 3-4 at the Hilton Garden Inn Albany Medical Center.
Speakers at the symposium, hosted by Albany Medical College and New York Oncology Hematology, P.C. (NYOH) and jointly sponsored by the Medical College of Wisconsin, include:
• David Jablons, M.D., chief of Thoracic Surgery at the University of California, San Francisco Medical Center and an Albany Medical College graduate, is a sought-after national and international speaker on lung cancer and has written numerous researcher papers on the subject. He will discuss identification of stem cell pathways for the treatment of lung cancer.
• Lajos Pusztai M.D., D.Phil., co-director of the Cancer Genetics Research at Yale Medical Center, is a distinguished medical oncologist and one of the nation’s leading researchers in breast cancer, particularly in the development of targeted therapies for the disease. He leads the breast cancer medical oncology team at Yale’s Smilow Cancer Hospital.
• Jeffrey Ross, M.D., chair of Albany Med’s Department of Pathology and Laboratory Medicine, will discuss how breakthroughs in diagnostic and predictive tools are paving the way for individualization of cancer treatment. Dr. Ross is an expert in the fields of pathology, molecular diagnostics, oncology and translational cancer research.
The symposium provides an opportunity for physicians and scientists to partner to enhance understanding and collaboration and foster practical translational oncology in the Capital and Adirondack regions of New York. The ultimate goal is improved patient care.
Lawrence Garbo, M.D., chairman of the NYOH Research Committee, will make opening and closing remarks and Vincent Verdile, M.D., dean of Albany Medical College and executive vice president for health affairs at Albany Medical Center, will be a symposium moderator.
The conference begins Thursday afternoon and goes through Friday, when a series of panel presentations will focus on issues in breast cancer, sarcomas, genitourinary cancers, and lung cancer.
Media interested in talking to one of the keynote speakers or panelists should contact Mark McGuire at 518-262-3421 (email@example.com) to set up a time.
For more information and an agenda, visit www.TransOncNY.org.
Albany Medical Center, northeastern New York’s only academic health sciences center, is one of the largest private employers in the Capital Region. It incorporates the 651-bed Albany Medical Center Hospital, which offers the widest range of medical and surgical services in the region, and the Albany Medical College, which trains the next generation of doctors, scientists and other healthcare professionals, and also includes a biomedical research enterprise and the region’s largest physicians practice with nearly 400 doctors. Albany Medical Center works with dozens of community partners to improve the region’s health and quality of life. For more information: www.amc.edu or www.facebook.com/albanymedicalcenter .
Statistical information presented in press releases may no longer be valid.